Over the past year, the Hair Restoration Laboratories’ Professional Strength DHT Blocking Hair Loss Shampoo (and accompanying DHT Blocking Hair Loss Conditioner) has been a top seller on Amazon and many other sites. Combined, the daily use Shampoo and Conditioner has more DHT blockers than any shampoo/conditioner set presently available. Among the key DHT Blockers in this set are: Caffeine, Saw Palmetto, Black Cumin Seed Oil, Cayenne Fruit Extract, Rosemary Leaf Oil, Pumpkin Seed Oil, Green Tea Leaf Extract, Pea Extract and many more. By helping to block DHT, they should be a great asset in helping to halt the miniaturization of the hair follicles and regrow healthier and thicker hair.
Key features: This classic anti-dandruff shampoo by Nizoral uses ketoconazol, an anti-fungal medication, as its main ingredient to treat flaking, scaling, itching, or inflammation caused by seborrheic dermatitis, and is still gentle enough to be used on fine or thinning hair. It's meant to be used just twice a week in between regular shampoos to manage dandruff.
Hair growth is a giant industry, with estimated annual sales of $3.6 billion. And every one of those dollars goes to products that do not provide actual hair regeneration. Rogaine and Propecia, the market leaders, can slow hair loss, but they don’t grow new hair. They also come with the small risk of serious side effects. In 2011, Men’s Health reported on a Propecia user who “lost all pleasurable sensations in his penis.”
Of course, there are plenty of men who wish desperately to restore their youthful locks, and a few — we can think of one powerful one — who cling to elaborate comb-overs, but many balding men simply clip their hair short and go on with their lives. Dermatologists say hair loss is emotionally harder for women, who are often deeply embarrassed by thinning hair even though it's quite common. By the time they reach 50, about 40 percent of women are experiencing what's known as female-pattern hair loss, said Gopal Patel, a dermatologist with Aesthetic Dermatology Associates in Media. Women of African descent struggle with even more conditions that can damage hair follicles and cause bald spots.
Drugs normally used for rheumatoid arthritis and bone marrow cancer, they are now being studied for their uses as a hair growth medicine. These are a new class of medicines labeled as JAK inhibitors. In one study, 6 out of 9 patients dramatically went from bald to a full head of hair after taking Ruxolitinib for 5 months. In another study several subjects were able to regrow full heads of hair. Unfortunately, sustained use of such drugs will have severe side effects. Many of these concerns would be side stepped if a topical formula could be developed. Researchers at the Department of Dermatology and Genetics and Development at Columbia University Medical center are now studying other JAK inhibitors in placebo controlled studies.
Central centrifugal cicatricial (scarring) alopecia: This type of hair loss occurs most often in women of African descent. It begins in the center of the scalp. As it progresses, the hair loss radiates out from the center of the scalp. The affected scalp becomes smooth and shiny. The hair loss can be very slow or rapid. When hair loss occurs quickly, the person may have tingling, burning, pain, or itching on the scalp. Treatment may help the hair re-grow if scarring has not occurred.
Niacin, also known as vitamin B3, is another vitamin that you can find in a lot of men’s hair loss shampoos. Like biotin, niacin and its derivatives are scientifically proven to increase hair growth when topically applied to hair growth areas over the course of several months. However, it's important to call out that this pilot study used female participants.
Learn to get used to it. Men with balding hair would like to wear caps as a way to mask or cover-up their thinning hair. But while this is understandable, wearing a cap will not make the issue go away. Rather, by teaching oneself to get used to your new look, the easier it will be to accept and the less awkward you'd feel if you're out in public. Wear a hat only when necessary, that is, if you need scalp protection.
Dr. Carlos Wesley, a hair restoration surgeon in Manhattan, said that women in his practice respond better to P.R.P. than men do, which may have something to do with the fact that women with genetic hair loss tend to have more inflammatory cells around the follicles. From 2013 to 2014, he said, he had an 83 percent increase in female patients, in part because of P.R.P.
Thanks so much for the guidance! After further research I have to agree with you 100%. Lipogaine Big 3 does containe ketoconazole, which would eliminate the need for Nizoral, however the shampoo only contains a few hair loss/thinning related ingredients. The Big 5 contains 17 and just seems like a better overall product. That plus Nizoral twice weekly seems pretty solid to me.
The Rogaine rep we spoke to explained that the different packaging (and therefore different prices) has to do with the FDA-approval process: “We discovered in clinical trials that the hair loss patterns between men and women are different,” she said by way of explanation. “Men typically have that bald spot on the crown of their head, where women generally have a general thinning throughout, but concentrated more on the top of the head. So for FDA approval, we had to come up with two different, gender-specific products, so the directions were more explanatory.”
A separate study, published in Skin Therapy Letter — a professional reference site for dermatologists — found that women also benefit from using the more potent 5 percent minoxidil treatment. “Patient-reported improvement in hair volume and coverage appears to be greater with 5 percent minoxidil foam,” reads the report. Plus, because the 5 percent treatment is stronger, women only have to apply it once a day to get the same results as they would with the 2 percent treatment applied twice daily.
Dupilumab is FDA approved for treating eczema aka atopic dermatitis and sold under the brand name Dupixent. As the story goes, a patient with alopecia totalis (a form of areata which leaves a person’s head completely bald) was being treated for eczema by the drug Dupixent. After 6 weeks the patient first began to notice progress in terms of hair growth and at 7 months she had noticeable pigmented hair growth on her scalp. Notably, the patient stopped taking the dupilumab for a period of time and noticed her growth subsided; when she began taking the drug again the hair improved once more. This provides another useful therapy option for patients seeking treatment for AA. One would imagine a topical version would be worthwhile to investigate.